Blar i SIHF Open Archive på forfatter "Mikkelsen, Knut"
-
Levels of Lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: A cross-sectional study
Holm, Sverre; Oma, Ingvild; Hagve, Tor-Arne; Saatvedt, Kjell; Brosstad, Frank Roger; Mikkelsen, Knut; Rydningen, Hans; Risnes, Ivar; Almdahl, Sven Martin; Ueland, Thor; Aukrust, Pål; Halvorsen, Bente; Hollan, Ivana (Journal article; Peer reviewed, 2019)OBJECTIVES: Patients with various inflammatory rheumatic diseases (IRDs) have increased risk of atherothrombotic disease. Lipoprotein (a) (Lp(a)) is a risk factor for atherosclerosis but its role in IRD with accompanying ... -
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Deyab, Gia; Hokstad, Ingrid; Whist, Jon Elling; Småstuen, Milada C; Agewall, Stefan; Lyberg, Torstein; Ronda, Nicoletta; Mikkelsen, Knut; Hjeltnes, Gunnbjørg; Hollan, Ivana (Journal article; Peer reviewed, 2017)Background Inflammatory arthritis (IA), including rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA), leads to increased cardiovascular disease occurrence probably due to atherosclerosis. ... -
Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases
Shields, Kelly J.; Mollnes, Tom Eirik; Eidet, Jon Roger; Mikkelsen, Knut; Almdahl, Sven Martin; Bottazzi, Barbara; Lyberg, Torstein; Manzi, Susan; Ahearn, Joseph M.; Hollan, Ivana (Journal article; Peer reviewed, 2017)Purpose Inflammatory rheumatic diseases (IRD) are associated with accelerated coronary artery disease (CAD), which may result from both systemic and vascular wall inflammation. There are indications that complement may ...